Induction of HIV neutralizing antibody lineages in mice with diverse precursor repertoires
-
-
[1] Howard Hughes Medical Institute
Howard Hughes Medical Institute
Estados Unidos
-
[2] National Institute of Allergy and Infectious Diseases
National Institute of Allergy and Infectious Diseases
Estados Unidos
-
- Localización: Cell, ISSN 0092-8674, Vol. 166, Nº. 6, 2016, págs. 1471-1484
- Idioma: inglés
- Texto completo no disponible (Saber más ...)
-
Resumen
The design of immunogens that elicit broadly reactive neutralizing antibodies (bnAbs) has been a major obstacle to HIV-1 vaccine development. One approach to assess potential immunogens is to use mice expressing precursors of human bnAbs as vaccination models. The bnAbs of the VRC01-class derive from the IGHV1-2 immunoglobulin heavy chain and neutralize a wide spectrum of HIV-1 strains via targeting the CD4 binding site of the envelope glycoprotein gp120. We now describe a mouse vaccination model that allows a germline human IGHV1-2∗02 segment to undergo normal V(D)J recombination and, thereby, leads to the generation of peripheral B cells that express a highly diverse repertoire of VRC01-related receptors. When sequentially immunized with modified gp120 glycoproteins designed to engage VRC01 germline and intermediate antibodies, IGHV1-2∗02-rearranging mice, which also express a VRC01-antibody precursor light chain, can support the affinity maturation of VRC01 precursor antibodies into HIV-neutralizing antibody lineages.
